Abstract: Natural sulphurated amino acids are cysteine and methionine. Their importance in biological processes is largely known. Cysteine, plays a key role due to the thiol group, which represents a nucleophilic and easily oxidizable function. Synthetic methodologies to obtain Cysteine-, Methionineand Seleno-Cysteine-Proline chimeras are strongly desirable and particularly appealing in the field of organic chemistry.
INTRODUCTION
In proteins, free Cysteine (Cys) has a hydrophilic character, as hydrogen bond donor, while when covalently bonded each other, Cys residues have a crucial role in determining and stabilizing the conformation of protein and peptides [1, 2] . Methionine (Met) contributes to conformational properties of proteins through the Met-aromatic motif, a hydrophobic interaction that provides an additional stabilization [3] .
Structure's modification on peptides is always responsible of changes in their biological activities, because a specific constraint, such as that imposed by unnatural amino acids, may destabilize the interactions between the ligand and the protein.
Methionine is an interesting amino acid residue in biologically active peptides; its conformationally constrained analogues are subdivided into two, well-documented classes ( Fig. 1) [4] [5] [6] [7] [8] .
Conformational profile of N-acetyl, N'-methylamide derivatives of cis-and trans-3-methyl-proline shows an inverse -turn structure more stable than that of cis-3-methyl-proline [9] , furthermore C C and N CO cyclizations are two complementary constraints.
The -stereocenter of proline amino acid determinates the amino acid side chain orientation in biologically active peptides binding to receptor [10] .
To further delineate the molecular interactions of this Cterminal amino acid with both binding sites of the human NK-1 tachykinin receptor, Sugase et al. [11] have designed *Address correspondence to this author at the Dipartimento di Farmacia, Università di Chieti-Pescara "G. d'Annunzio", Via dei Vestini 31, 66100 Chieti, Italy; Tel: 0871-3554476; E-mail: a.mollica@unich.it constrained analogs of methionine, i.e. 3-prolinomethionines. The resulting analogs completely lose NK-1 biological activity [12] , a result which may come from the non-accurate fixed value of the 2 angle on the pyrrolidine ring. In contrast, 3-prolinoamino acids [13] , combine the proline constraint on the peptide backbone (fixed 1 angle) with the presence in position 3 (or ) on the pyrrolidine ring of the native amino acid side chain with a flexible 2 angle.
Enomoto et al. [14] investigated the structural modifications of N-mercaptoacyl-L-proline and (4R)-N-mercaptoacylthiazolidine-4-carboxylic acid to build efficient leukotriene A4 (LTA 4 ) hydrolase inhibitors. The (2S)-3-mercapto-2-methylpropionyl group was chosen for both of them (Fig. 2) .
The insertion of 4-isopropylbenzylthio, 4-tertbutylbenzylthio or 4-cyclohexylbenzylthio group with (S)-configuration at the C-4 position of proline, gave strong LTA 4 hydrolase inhibitors.
The syntheses of 3-proline-methionine and 4-prolinemethionine chimeras have been performed via Zinc-enolate cyclization and Mitsunobu reaction in diastereoselective and enantioselective way (Fig. 3). 
3-SUBSTITUTED CYSTEINE-PROLINE AND ME-THIONINE-PROLINE CHIMERAS SYNTHESES

5-Exo-Trig-Cyclization via Zinc Enolate
The first synthesis of a 3-proline-methionine chimera (3-methylsulfanylmethyl-pyrrolidine-l,2-dicarboxylic acid dimethyl ester) has been described by Udding et al. [15] which involves xanthate transfer cyclization of a glycine radical, leading to non-regiospecific and non-diastereoselective reaction.
A more general strategy via Zinc-enolate cyclization, was reported by Karoyan and Chassing [16] . The organozinc derivative was treated with iodine to give ethyl cis-3-iodomethyl-N-benzylprolinate, which was alkylated by the sodium salt of methanethiol to yield the cis-3-prolinemethionine analogs as racemic mixture. A one-pot procedure could be also applied modifying the carbanionic species and using an electrophilic sulfur donor, so as the stereogenic center on the N-protecting group generates an asymmetric C-2 carbon atom center. The lithium enolate of (-)-1 was transmetallated (3 eq. of dried ZnBr 2 at -90°C) to yield cis diastereoselective cyclization, the reaction mixture was cooled to 0°C and the second transmetallation reaction was carried out (1.2 eq. of CuCN 1M, LiCl in THF at 0°C for 10 min.), then (S)-methyl methanesulfonothiolate was added.
Easy cleveage of the cuprozinc compound was achieved giving the 3-methyl-sulfanylmethyl-l-(1-phenyl-ethyl)-pyrrolidine-2-carboxylic acid ethyl ester 2 in 2S,3R configuration.
Olofson et al. [18] used vinylchloroformate for Ndealkylations on product 2, despite the slow reaction's rate, then voc group was removed from 3 by HCl in dioxane.
Tert-butoxycarbonyl (N-Boc) protection and saponification gave (2S,3R)-Boc 3-proline-methionine 4 as crude mixture, which was following purified by silica gel chromatography.
An alternative route was proposed starting from (+)--methylbenzylamine to give (2R,3S)-benzyl-Voc-3-prolinemethioninate 5, which was deprotonated by LDA in THF at -78 °C obtaining an inversion of configuration at the C carbon over 90% (as determined by NMR).
Enantiomerically pure (2S,3S)-benzyl-Voc-3-prolinemethioninate 6 was isolated after flash chromatography. Boc 2 O protection and saponification gave the (2S,3S)-Boc 3-proline-methionine 7.
As a continuation of their studies concerning solid-phase amino-Zinc-enolate cyclization, Karoyan et al. [19] explored the iodo derivative 8 functionalization (Scheme 2).
Compound 8 was reacted with two kinds of nucleophiles sodium thiophenate and p-nitrophenol in DMF, at 50°C. In the first case, compound 10 was characterized by mass spectroscopy after cleavage of 9 from the resin while in the second case, 2 eq. of nucleophile were used with K 2 CO 3 giving nucleophilic substitution of the halogen atom and cleavage of the product from the resin. 
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LDA, H + , -78°C [17] . PhSNa DMF Scheme 2. Functionalization of the iodo derivative [19] .
Scheme 1. Synthesis of (2S, 3R)-and (2S, 3S)-prolinomethionine
Basic conditions applied during the work-up of the reaction cleaved the p-nitrophenol ester providing compounds 11 and 12.
Via Dihydroproline Intermediate Formation
Kolodziej et al. [20] Conjugate addition of 4-methylbenzylmercaptan to 2,3-dehydroproline derivative 13, [21] and hydrolysis in acid conditions, provided the trans-diastereomer 14 following ripetitive crystallizations, in 52% yield. Compound 14 was protected with Boc 2 O to give derivative 15 as cyclohexylamine salt in 92% yield. In a similar manner, the cis-isomers were also obtained (Scheme 4). Scheme 4. Synthesis of diastereomeric mixture of protected 3-substituted proline [20] .
The 3-bromo-l,2-dehydroproline derivative 16 was described by Hausler and Schmidt [22] , and used to react with 4-methylbenzylmercaptan in aqueous sodium hydroxide; diastereoselective reduction with NaBH 4 provided the cisisomer D,L-17 in an overall yield of 37%.
4-SUBSTITUTED CYSTEINE-PROLINE AND ME-THIONINE-PROLINE CHIMERAS SYNTHESES
Mitsunobu Reaction
Selective CCK-B agonist can be prepared by substitution of the 31 [20] synthesized different Ac-CCK4 analogs containing 3-and 4-(alkylthio)-substituted proline derivatives. A high-yielding synthetic strategy was developed to achieve the S-methylated derivatives 23 and 25 (Scheme 5).
Reaction of compound 20 with thiolacetic acid under Mitsunobu conditions is the key transformation, to provide derivative 21 in 85% yield [23] .
Derivative 23 was obtained in a one-pot reaction's sequence [23] involving two selective hydrolysis and alkylation, in 60% overall yield from 19. Mitsunobu inversion of the C-4 carbon of 20 was performed using formic acid, followed by hydrolysis of the formate ester to yield 22 in 64%. Then 25 was obtained in an overall yield of 45% from 19, following the reaction's sequence described above. Recently Mollica et al. [24] 
investigated new fMLF analogs incorporating chimeric L-proline-methionine residues, namely the homochiral cis-4(S)-methylthio-(S)-proline 28 and the heterochiral trans-4(R)-methylthio-(S)-proline 35, in which -
thiomethyl-ether functionality is preserved. Cis-and trans-4-methylthio-proline derivatives can be prepared following different approaches [25] .
To obtain N-Boc-cis-4(S)-methylthio-(S)-proline 28 and N-Boc-trans-4(R)-methylthio-(S)-proline 35,
the N-protected cis-analog 28 was prepared from 4-hydroxy-trans-proline 29 treating the corresponding N-Boc-trans-4-mesylate 26 with potassium thioacetate, followed by hydrolysis of the derivative 27 and alkylation of the thiol group (Scheme 6).
The N-Boc derivative 29 was prepared to build N-Boctrans-analog 34 (Scheme 7).
In this case, two configurational inversions at C-4 occurred; the first involved the formation of the 4-oxo-analog 30 which, after stereoselective reduction with NaBH 4 , gave the N-Boc-(2S,4S)-cis-isomer 31. 
4-SELENO-CYSTEINE-PROLINE CHIMERAS SYNTHESES
Mitsunobu Reaction
The preparation of Seleno-Cysteine-Pro chimeras is particularly interesting since its use in native chemical ligation (NCL) in several papers [26] [27] [28] [29] .
One of the first attempt to synthesize these chimeras was done by Rüeger and Benn for the (S)-3,4-dehydroproline starting from (2S,4R)-4-hydroxyproline [30] , considering that selenoxide elimination can be regioselective if the required 3-ene function could be introduced (Scheme 8).
This protocol was applied successively by Robinson et al. [31] for the synthesis of a series of epoxyprolines and aminohydroprolines.
For this purpose, 3,4-dehydro-L-proline derivative was prepared from trans-hydroxy-L-proline 37 using a modified version of the method reported by Rüeger and Benn (Scheme 9) [30] . [24] . Treatment of derivative 42 with tosyl chloride/pyridine failed to give tosylate 44 in good yield. Then 1-(toluenesulphonyl)-3-methylimidazolium triflate 43 was chosen to prepare product 44 in acceptable yield. Reaction of 44 with PhSeSePh/NaBH 4 in tert-butanol furnished 45 without transesterification. Durek and Alewood have studied the conversion of thioesters to selenoesters to give highly reactive C-terminal ligation partners [32] . Also Metanis et al. [33] have described the ligation and the deselenization of peptide-feature N-terminal selenocysteine residues. Thus trans-seleno-proline, was synthesized for the first time (Scheme 10). Beginning with the commercially available pyrrolidine 46, Mitsunobu inversion gave the cis-iodo-proline 47, in good yield. Treatment with selenobenzoic acid provided compound 48 in 84% yield. Removal of the benzoate and saponification occurs in concert to give N-Boc selenoproline dimer 49, in 79% yield which was finally removed under acidic conditions to afford oxidatively dimerized 50.
Scheme 7. Synthesis of trans-4(R)-methylthio-(S)-proline
S N 2 Reaction
Starting from 4-hydroxylproline, Caputo et al. [34] reported a new procedure to prepare sulphur and selenium containing bis -amino acids. The existing hydroxyl group of trans-4-hydroxy-L-proline was involved in S N 2 process, for which inversion of C-4 configuration occurred. Although trans configuration was maintained transforming the hydroxyl group either into its tosyl ester or by substitution with an iodine complex, giving the cis-4-iodo-L-proline. Cysteinyl nucleophile attack provided trans-4-(S)-cysteinyl-L-proline 53 from compound 51 and cis-4-(S)-cysteinyl-L-proline 54 from derivative 52; diastereomeric trans/cis 4-selenocysteinyl-Lprolines 55 and 56 were finally obtained with the addition of selenocysteinyl nucleophile (Scheme 11) [35] .
CONCLUSION
This review is focused on Met, Cys, and Cys-Seleno Proline chimeras. The most important synthetic strategies reported in literature to prepare these chimeric compounds have been reported and discussed. They are particularly important in peptidomimetics design; for example, Wi niewski reported a small library of oxytocin analogues [36] , which show selectivity to vasopressin receptors and present several chemical modification, including the introduction of trans-4-SMe-Pro residue in peptide 57 (Fig. 4) . This class of compounds can be considered central in the field of peptide-based drug discovery [37] , due to the remarkable effects of proline and cysteine on peptides secondary structures.
